RNDr. Pavel Krejčí, Ph.D.
Head of the research group, Pavel Krejčí Research Group
Office: bldg. C03/246
Kamenice 753/5
625 00 Brno
Phone: | +420 549 49 5395 |
---|---|
E‑mail: |
social and academic networks: |
---|
Total number of publications: 118
2018
-
Colicin F-Y inhibits pathogenic Yersinia enterocolitica in mice
Scientific reports, year: 2018, volume: 8, edition: 12242, DOI
-
Computer-assisted engineering of hyperstable fibroblast growth factor 2
Biotechnology and Bioengineering, year: 2018, volume: 115, edition: 4, DOI
-
Inhibition of SHIP2 activity inhibits cell migration and could prevent metastasis in breast cancer cells
Journal of Cell Science, year: 2018, volume: 131, edition: 16, DOI
-
Nanodiamonds as "artificial proteins": Regulation of a cell signalling system using low nanomolar solutions of inorganic nanocrystals
Biomaterials, year: 2018, volume: 176, edition: SEP 2018, DOI
-
Proteomic analyses of signalling complexes associated with receptor tyrosine kinase identify novel members of fibroblast growth factor receptor 3 interactome
Cellular Signalling, year: 2018, volume: 42, edition: JAN 2018, DOI
-
Registr Achondroplasie na Slovensku a v České republice
Year: 2018, type:
-
Registr Achondroplázie REACH
Year: 2018, type:
-
Regulation of ciliary function by fibroblast growth factor signaling identifies FGFR3-related disorders achondroplasia and thanatophoric dysplasia as ciliopathies
Human molecular genetics, year: 2018, volume: 27, edition: 6, DOI
-
The inositol phosphatase SHIP2 enables sustained ERK activation downstream of FGF receptors by recruiting Src kinases
SCIENCE SIGNALING, year: 2018, volume: 11, edition: 548, DOI
-
The PTH/PTHrP-SIK3 pathway affects skeletogenesis through altered mTOR signaling
Science Translational Medicine, year: 2018, volume: 10, edition: 459, DOI